Glenmark Brings Brukinsa to India—A New Era in Blood Cancer Treatment!

Unknown Apr 02, 2026 650 Views

Glenmark Pharmaceuticals Ltd. has announced the launch of Zanubrutinib in India, marketed under the brand name Brukinsa, following approval from the Drug Controller General of India (DCGI). This marks a major milestone in the availability of advanced treatments for hematological malignancies, par...